The Food and Drug Administration (FDA) has announced a new initiative aimed at accelerating the approval process for biosimilar drugs, which are less expensive alternatives to...
The U.S. Food and Drug Administration (FDA) has announced the first group of drugs that will undergo expedited review processes. This initiative is part of a...
Health and Human Services Secretary Robert F. Kennedy Jr. is advancing a controversial strategy aimed at reforming the federal Vaccine Injury Compensation Program (VICP), which has...
